Back to top of page

NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)

List of required information for application:

1. Name of small business concern (SBC)

2. Description of the technology being developed for heart, lung, blood, and sleep disorders and diseases

3. Previous SBIR or STTR Phase II awards received for the project

4. Summary of the milestones achieved during the Phase II award

5. Funding gap between the end of the Phase II award and the commercialization stage

6. Plan for later-stage research and development (Phase IIB)

7. Description of the regulatory approval/clearance process required for the product

8. Strategy for partnering with third-party investors and/or strategic partners

9. Budget for the Phase IIB project

10. Timeline for achieving regulatory approval and commercialization 

11. Potential impact of the technology on public health

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows